Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the immune microenvironment for ovarian cancer therapy
Félix Blanc‐Durand, Lai Clemence Wei Xian, David S.P. Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19

Showing 19 citing articles:

Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment
Stefania Drymiotou, Efthymia Theodorou, Kathrine S Rallis, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 545-545
Open Access
Oxidation of retromer complex controls mitochondrial translation
Junbing Zhang, Md Yousuf Ali, Harrison B. Chong, et al.
Nature (2025)
Closed Access
Exploit the γ-Glutamyl hydroxymethyl rhodamine green fluorescence in surgical resection: A systematic literature review on clinical indications, fields of application and outcomes
Salvatore Marrone, Gianluca Scalia, Oday Atallah, et al.
Neurosurgical Review (2025) Vol. 48, Iss. 1
Closed Access
Multiomics evaluation and machine learning optimize molecular classification, prediction of prognosis and immunotherapy response for ovarian cancer
Fang Ren, Xiaoao Pang, Ning Liu, et al.
Pathology - Research and Practice (2025), pp. 155925-155925
Closed Access
Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics
Joanna Mikulak, Sara Terzoli, Paolo Marzano, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
From Gene Editing to Tumor Eradication: The CRISPR Revolution in Cancer Therapy
Ashiq Ali, Urooj Azmat, Aisha Khatoon, et al.
Progress in Biophysics and Molecular Biology (2025)
Closed Access
Inflammatory Indices and CA 125: A New Approach to Distinguish Ovarian Carcinoma and Borderline Tumors in Suspicious Ovarian Neoplasms from a Retrospective Observational Multicentric Study
Carlo Ronsini, Stefano Restaino, Giuseppe Vizzielli, et al.
Medicina (2025) Vol. 61, Iss. 5, pp. 777-777
Open Access
From Defense to Disease: How the Immune System Fuels Epithelial–Mesenchymal Transition in Ovarian Cancer
Michał Kos, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4041-4041
Open Access
Bioinformation study of immune microenvironment characteristics of disulfidptosis-related subtypes in ovarian cancer and prognostic model construction
Ying Zhou, Y Zhang, Yang Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Col1A1 as a new decoder of clinical features and immune microenvironment in ovarian cancer
Xiao Xiao, Fangyi Long, Shaolan Yu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer
Jiahui Li, Hasan Al Faruque, Shannuo Li, et al.
Journal of Controlled Release (2025), pp. 113682-113682
Open Access
Refining molecular subtypes and risk stratification of ovarian cancer through multi‐omics consensus portfolio and machine learning
J Zhang, Shanshan He, Hongjun Ying
Environmental Toxicology (2024)
Closed Access | Times Cited: 3
Apoptosis, a Metabolic “Head-to-Head” between Tumor and T Cells: Implications for Immunotherapy
Ornella Franzese, Pietro Ancona, Nicoletta Bianchi, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 924-924
Open Access | Times Cited: 2
Comprehensive analysis of the interaction of antigen presentation during anti‐tumour immunity and establishment of AIDPS systems in ovarian cancer
Wenhuizi Sun, Ping Xu, Kefei Gao, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1
A disulfidptosis-related lncRNAs cluster to forecast the prognosis and immune landscapes of ovarian cancer
Jiahui Wei, Ming Wang, Yumei Wu
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Unveiling Commonalities: Exploring Shared Characteristics in Clear Cell Carcinomas of the Gynecologic Tract
Félix Blanc‐Durand, Natalie Ngoi, Diana Lim, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4557-4565
Closed Access | Times Cited: 1
Research progress of immune checkpoint inhibitors in ovarian cancer
Lingli Zhao, Yanhong Zhai, Gaoli Niu
Exploration of Immunology (2024), pp. 853-870
Open Access
Research progress on the influence of traditional Chinese medicine on tumor microenvironment therapy
Kun Gao, Yang Cao, Zixin Ning, et al.
IntechOpen eBooks (2024)
Open Access
Page 1

Scroll to top